PT-141 10mg (Canada) – Research Use Only

PT-141 10mg Canada – Research Material

PT-141 10mg Canada from Nordexa Research is supplied as lyophilized material in a sealed 3 mL research vial for non-clinical laboratory research and analytical reference work. This page provides chemical reference identifiers, product specifications, and Canadian shipping information for qualified purchasers. Not for human consumption.

PT-141 is also referenced as bremelanotide in chemical databases. Nordexa’s PT-141 10mg listing is research material, not a finished prescription drug or consumer product, and no pharmaceutical equivalence, clinical suitability, or therapeutic outcome is claimed.

PT-141 10mg Product Specifications

• Product name: PT-141 10mg
• Reference name: Bremelanotide
• Labelled amount: 10 mg per vial
• Format: Lyophilized research material
• Container: Sealed 3 mL research vial
• Shipping origin: Ontario, Canada
• Minimum age: 21+ required to order

Chemical Reference Identifiers

The following identifiers are included to help researchers distinguish PT-141 Canada documentation from similarly named materials:

• Research designation: PT-141
• Reference name: Bremelanotide
• Molecular formula: C₅₀H₆₈N₁₄O₁₀
• CAS Registry Number: 189691-06-3
• PubChem CID: 9941379

These identifiers describe the referenced compound only. They are not preparation, administration, dosing, safety, efficacy, or personal-use guidance.

Research-Use Positioning

PT-141 10mg Canada is offered only for non-clinical laboratory research, analytical reference work, and appropriate institutional evaluation. Nordexa Research does not promote this material for human or animal use, treatment, diagnosis, compounding, self-experimentation, or consumer resale.

Purchasers are responsible for reviewing applicable laws, institutional policies, laboratory controls, and handling requirements. Nordexa does not provide reconstitution instructions, dilution ratios, administration guidance, dosing information, protocols, cycle information, or medical advice.

Ordering PT-141 Canada from Ontario

Nordexa Research ships from Ontario, Canada. Current availability is displayed above the product description. When PT-141 Canada is out of stock, use the product-page notification option to receive an availability email rather than relying on an older search result or cached stock status.

Orders are limited to qualified purchasers aged 21 or older. Shipping timing and checkout options are displayed during ordering and may vary with stock status and destination.

Related Research Materials

Researchers comparing catalogue listings may also review Kisspeptin Canada 10mg, Melanotan II Canada 10mg, and Selank 10mg Canada. These are separate materials with their own product specifications. View the Nordexa research catalogue for current availability across all listings.

Frequently Asked Questions

Is PT-141 the same reference compound as bremelanotide?

PT-141 is a common research designation associated with bremelanotide. Nordexa’s listing is non-clinical research material and must not be treated as a finished prescription medicine or used as a substitute for one.

Is PT-141 10mg sold for human use?

No. PT-141 10mg from Nordexa Research is sold strictly for laboratory research use only. It is not sold for human consumption, treatment, diagnosis, veterinary use, or personal use.

Does Nordexa provide preparation or dosing instructions?

No. Nordexa Research does not provide preparation instructions, reconstitution guidance, dilution ratios, dosing guidance, administration guidance, or protocols.

Where does Nordexa ship from?

Nordexa Research ships from Ontario, Canada.

Compliance Notice: For research use only by qualified purchasers. Not for human consumption. Must be 21+ to order. Ships from Ontario, Canada.